Drug discovery company E-Therapeutics is planning a flotation on AIM later this month. The Newcastle-based company, which counts new therapy candidates in 11 clinical areas including MRSA, asthma and diabetes amongst its portfolio, is backed by Katalyst Ventures, Novotech Investment, NorthStar Equity Investors and RAB Capital.
Polish buyout firm Abris Capital Partners has signed an agreement to sell its stake in Polish locomotive lessor Cargounit, also known as Industrial Division, to Three Seas Investment Fund (3SIIF).
Amplify IV targets seed and series-A rounds, while Amplify Select makes follow-on investments in existing portfolio companies
GP had previously made an offer of SEK 70 per share, which was later increased to SEK 72 per share
Company intends to boost its production capability, bolster its international expansion and pursue a buy-and-build strategy